{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:11:26Z","timestamp":1781849486056,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.oret.2016.10.007","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T18:16:54Z","timestamp":1482257814000},"page":"181-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Systemic Sunitinib Malate Treatment for Advanced Juxtapapillary Retinal Hemangioblastomas Associated with von Hippel-Lindau Disease"],"prefix":"10.1016","volume":"1","author":[{"given":"Jared E.","family":"Knickelbein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naima","family":"Jacobs-El","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry E.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Cukras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine B.","family":"Meyerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9374","key":"10.1016\/j.oret.2016.10.007_bib1","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.oret.2016.10.007_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","article-title":"von Hippel-Lindau disease","volume":"46","author":"Singh","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2016.10.007_bib3","first-page":"495","article-title":"Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations","volume":"103","author":"Chew","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"10","key":"10.1016\/j.oret.2016.10.007_bib4","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0161-6420(02)01177-6","article-title":"Treatment of retinal capillary hemangioma","volume":"109","author":"Singh","year":"2002","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.oret.2016.10.007_bib5","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/j.1755-3768.2010.02008.x","article-title":"Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma","volume":"88","author":"Sachdeva","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.oret.2016.10.007_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/IAE.0b013e318030a290","article-title":"Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina","volume":"27","author":"Dahr","year":"2007","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.oret.2016.10.007_bib7","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ophtha.2008.04.033","article-title":"Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.oret.2016.10.007_bib8","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"9","key":"10.1016\/j.oret.2016.10.007_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.oret.2016.10.007_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.117.5.625","article-title":"VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma","volume":"117","author":"Chan","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2016.10.007_bib11","first-page":"75","article-title":"Von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma","volume":"102","author":"Chan","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"14","key":"10.1016\/j.oret.2016.10.007_bib12","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1517\/14656566.8.14.2359","article-title":"Sunitinib","volume":"8","author":"Rini","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.oret.2016.10.007_bib13","article-title":"Systemic sunitinib malate in the treatment of optic nerve hemangioblastomas","volume":"53","author":"Jacobs-El","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.oret.2016.10.007_bib14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1023\/A:1008213320642","article-title":"Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease","volume":"8","author":"Los","year":"1997","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.oret.2016.10.007_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","article-title":"Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular\u00a0endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas","volume":"136","author":"Girmens","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.oret.2016.10.007_bib16","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0161-6420(02)01159-4","article-title":"Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor su5416","volume":"109","author":"Aiello","year":"2002","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.oret.2016.10.007_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1634\/theoncologist.12-1-107","article-title":"Food and Drug Administration drug approval summary: sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma","volume":"12","author":"Rock","year":"2007","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.oret.2016.10.007_bib18","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/annonc\/mdr011","article-title":"Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease","volume":"22","author":"Jonasch","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.oret.2016.10.007_bib19","unstructured":"Sutent Prescribing Information.\u00a02011. Pfizer Labs. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/021938s13s17s18lbl.pdf. Accessed April 21, 2016."},{"issue":"2","key":"10.1016\/j.oret.2016.10.007_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0025-6196(11)60847-1","article-title":"Ranibizumab combined with low-dose sorafenib for exudative age-related macular degeneration","volume":"83","author":"Diago","year":"2008","journal-title":"Mayo Clin Proc"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653016300392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653016300392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:23:02Z","timestamp":1762852982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653016300392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2468653016300392"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2016.10.007","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Sunitinib Malate Treatment for Advanced Juxtapapillary Retinal Hemangioblastomas Associated with von Hippel-Lindau Disease","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2016.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}